An intensified dosing schedule of subcutaneous methotrexate in patients with moderate to severe plaque-type psoriasis (METOP): a 52 week, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial-Reference-Cited by-同舟云学术

An intensified dosing schedule of subcutaneous methotrexate in patients with moderate to severe plaque-type psoriasis (METOP): a 52 week, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Published:2017-02 Issue:10068 Volume:389 Page:528-537
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Warren Richard B,Mrowietz Ulrich,von Kiedrowski Ralph,Niesmann Johannes,Wilsmann-Theis Dagmar,Ghoreschi Kamran,Zschocke Ina,Falk Thomas M,Blödorn-Schlicht Norbert,Reich Kristian

Publisher

Elsevier BV

Subject

General Medicine

Reference28 articles.

1. Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial;Reich;Lancet,2005

2. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2);Papp;Lancet,2008

3. Secukinumab in plaque psoriasis—results of two phase 3 trials;Langley;N Engl J Med,2014

4. US perspectives in the management of psoriasis and psoriatic arthritis: patient and physician results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) survey;Lebwohl;Am J Clin Dermatol,2016

5. Methotrexate for psoriasis in the era of biological therapy;Warren;Clin Exp Dermatol,2008

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psoriasis as a systemic disease;Deutsches Ärzteblatt international;2024-07-12

2. Treatment of Nail Psoriasis;Dermatologic Clinics;2024-07

3. Basic Susceptibility of Patients with Psoriasis under Systemic Therapy for Respiratory Infections: Data from the German Psoriasis Registry PsoBest;Journal of Clinical Medicine;2024-06-26

4. Molecular mechanisms underlying methotrexate-induced intestinal injury and protective strategies;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-06-01

5. Retrospective Cohort Study Comparing Efficacy and Safety of Pharmacological Intervention and Phototherapy in Moderate to Severe Psoriasis Patients in a Real-World Setting;Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.;2024-04-01